Evidence map›Paper›PMID 23989679›Full record

ArticleJAMA2013

Improved blood pressure control associated with a large-scale hypertension program.

Marc G Jaffe, Grace A Lee, Joseph D Young, Stephen Sidney, Alan S Go

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in JAMA, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04841317 (Implementing a Mobile Technology-Based System for Physician-Directed Remote Management of Hypertension), which is not on this map. Cited by 294 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
294citing papers in PubMed, 11 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04841317 nacompletednot on this mapstarted 2021, after this paper: background citation

Implementing a Mobile Technology-Based System for Physician-Directed Remote Management of Hypertension: A Pilot Study

TypeinterventionalSponsorStanford UniversityRan2021 to 2021Enrolled31ConditionsHypertensionArmsMobile technology intervention
3 · Its place in the literature

Who cites it

294 citing papers in PubMed, 11 syntheses or guidelines pooled it.

  1. Guideline
  2. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Guideline
  3. Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Guideline
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Guideline
  8. Guideline
  9. Guideline
  10. Pooled it
  11. Guideline
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

234 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Marc G JaffeDepartment of Endocrinology, Kaiser Permanente South San Francisco Medical Center, South San Francisco, California 94080, USA. marc.jaffe@kp.org
Grace A Lee
Joseph D Young
Stephen Sidney
Alan S Go

Funding

HMO Research Network Cardiovascular Research NetworkU19HL091179 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI GO, ALAN S · 2007 to 2011
$8.7M
Development of a Cardiovascular Surveillance System in the CVRNRC2HL101666 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI SIDNEY, STEPHEN · 2009 to 2010
$7.2M
NHLBI NIH HHS RC2 HL101666NHLBI NIH HHS U19 HL091179NHLBI NIH HHS U19 HL91179-01
6 · The paper itself

Abstract

importanceHypertension control for large populations remains a major challenge.

objectiveTo describe a large-scale hypertension program in Northern California and to compare rates of hypertension control in that program with statewide and national estimates. DESIGN, SETTING, AND PATIENTS: The Kaiser Permanente Northern California (KPNC) hypertension program included a multifaceted approach to blood pressure control. Patients identified as having hypertension within an integrated health care delivery system in Northern California from 2001-2009 were included. The comparison group comprised insured patients in California between 2006-2009 who were included in the Healthcare Effectiveness Data and Information Set (HEDIS) commercial measurement by California health insurance plans participating in the National Committee for Quality Assurance (NCQA) quality measure reporting process. A secondary comparison group was included to obtain the reported national mean NCQA HEDIS commercial rates of hypertension control between 2001-2009 from health plans that participated in the NCQA HEDIS quality measure reporting process. MAIN OUTCOMES AND MEASURES: Hypertension control as defined by NCQA HEDIS.

resultsThe KPNC hypertension registry included 349,937 patients when established in 2001 and increased to 652,763 by 2009. The NCQA HEDIS commercial measurement for hypertension control within KPNC increased from 43.6% (95% CI, 39.4%-48.6%) to 80.4% (95% CI, 75.6%-84.4%) during the study period (P < .001 for trend). In contrast, the national mean NCQA HEDIS commercial measurement increased from 55.4% to 64.1%. California mean NCQA HEDIS commercial rates of hypertension were similar to those reported nationally from 2006-2009 (63.4% to 69.4%). CONCLUSIONS AND RELEVANCE: Among adults diagnosed with hypertension, implementation of a large-scale hypertension program was associated with a significant increase in hypertension control compared with state and national control rates. Key elements of the program included a comprehensive hypertension registry, development and sharing of performance metrics, evidence-based guidelines, medical assistant visits for blood pressure measurement, and single-pill combination pharmacotherapy.

Indexed as

Disease ManagementQuality ImprovementAdolescentAdultAgedAged, 80 and overAntihypertensive AgentsBlood Pressure DeterminationCaliforniaDelivery of Health Care, IntegratedEvidence-Based MedicineFemaleHealth Maintenance OrganizationsHumansHypertensionMaleAntihypertensive Agents

Identifiers

PMID23989679
PMCPMC4270203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.